This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Manufacturing Services

Manufacturing Services

PCI Pharma Services provides full manufacturing services for both investigational and commercial products including highly potent molecules requiring specialist handling.

Through the acquisition of Penn Pharma, PCI has significant experience in providing integrated drug development, clinical trial supply and manufacturing services of solid dose potent products to high standards of safety and quality.

Development and Manufacturing of Highly Potent Molecules – A Center of Excellence

The pharmaceutical landscape continues to evolve with more and more products in development being deemed potent. As the biological activity and specificity of Active Pharmaceutical Ingredients (API) increases, dosage strengths are decreasing which had led to this increase in more potent molecules. Significant investment in general contained resources resulted in PCI being awarded ISPE Facility of the Year 2014. Additional investment include both contained roller compaction and fully contained Xcelodose® 600S technology, further driving PCI’s market leading position.

Our dedicated team of specialists will be happy to discuss any of our Pharmaceutical Manufacturing Services with you. Contact us on +1 779-774-1428 (US) or +44 1495 711 222 (UK) or email sales@pciservices.com


PCI Unveils Clinical Center of Excellence

Expanded Clinical Services Facility in Rockford, IL to Support Growth and Flexibility with 30,000 additional sq ft We have officially... View Article

Significant Investments at Ireland Site

PCI Strengthens Position in Europe with Investment in Ireland Latest development at Dublin site positions it at forefront of EU... View Article

x